Electric Literature of C22H25ClN6O2On November 1, 2017 ,《Design, synthesis and biological evaluation of WZ4002 analogues as EGFR inhibitors》 appeared in Bioorganic & Medicinal Chemistry Letters. The author of the article were Romu, Aireen A.; Lei, Zining; Zhou, Bin; Chen, Zhe-Sheng; Korlipara, Vijaya. The article conveys some information:
A series of thirty two anilinopyrimidines derived from WZ4002 has been synthesized and evaluated for percentage inhibition of six different EGFR kinases using LanthaScreen binding assay method (EGFR d746 – 750) or Z’LYTE assay method (EGFR-WT, EGFR d746 – 750, EGFR T790M, EGFR T790M L858R, EGFR C797S and EGFR T790M L858R C797S). Ortho-hydroxyacetamide I (R = 2′-NHCOCH2OH) exhibited complete inhibition of all the six kinases at 10 μM. Against the triple mutant, EGFR T790M C797S L858R, compounds I [R = 2′-NHCOCH2OCH2Ph, 2′-NHCOCH2OH, 2′-NHCO(CH2)2OCH2Ph, 2′-NHCO(CH2)2OH] exhibited complete inhibition at 10 μM and nearly complete inhibition at 1 μM. The target compounds were also evaluated using the MTT assay to determine their cytotoxic activity against human non-small cell lung cancer cells (PC9, PC9GR and H460) and mouse leukemic cells (Ba/F3 WT and Ba/F3T 3151). Overall, I [R = 2′-N3, 2′-NHCOCH2OCH2Ph, 2′-NHCOCH2OH, 2′-NHCO(CH2)2OCH2Ph, 2′-NHCO(CH2)2OH, 4′-NHCOCH2OCH2Ph, 4′-NHCOCH2OH] were found to be the most potent compounds across all five cell lines. In the experiment, the researchers used many compounds, for example, 4-(3-Aminophenoxy)-5-chloro-N-(2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)pyrimidin-2-amine(cas: 1213269-26-1Electric Literature of C22H25ClN6O2)
4-(3-Aminophenoxy)-5-chloro-N-(2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)pyrimidin-2-amine(cas: 1213269-26-1) is a member of pyrimidine. Pyrimidine derivatives are an important class of N-heterocycles. They are well-known for their wide spectrum of promising biological activities such as antitumors, bactericidals, and fungicidal.Electric Literature of C22H25ClN6O2
Referemce:
Piperazine – Wikipedia,
Piperazines – an overview | ScienceDirect Topics